Nissan Chemical Corporation
Notice Regarding Executive Personnel Changes
Announced executive and key personnel changes effective April 1, 2026, and June 25, 2026. Changes include reassignments of directors, executive officers, and board members, as well as establishment of new departments.
Key Figures
- Date of Executive Personnel Changes: Effective 2026-04-01
- Date of Annual General Meeting of Shareholders: 2026-06-25
- New Departments Established: Risk Management Department, Production Technology General Department, Production Technology Transformation Department, Healthcare Research Department
AI要約
Overview of Executive Personnel Changes
As of April 1, 2026, changes were made to the positions of directors, vice presidents, senior executive officers, executive officers, and board members. Hideki Daimon was appointed Vice President and CFO, and Ken Matsuoka was appointed CRO and General Manager of the Corporate Planning Department. The Risk Management Department was newly established, and organizational restructuring took place within the Production Technology Headquarters. The Healthcare Research Department was also newly established to strengthen the organizational structure.
Future Schedule and General Meeting of Shareholders
At the 156th Annual General Meeting of Shareholders scheduled on June 25, 2026, changes to auditors and executive officers will be officially decided. Kazuhiko Orai will be newly appointed as auditor, and Noriyuki Katayama will resign. These personnel changes aim to enhance corporate governance and improve management efficiency.
